Pandemic Timeline

AstraZeneca pauses COVID-19 vaccine trial when test subject exhibits a severe neurological reaction.

The study participant in late-stage testing reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, said company spokesman Matthew Kent.

The article also mentions another test subject who had “an undiagnosed case of multiple sclerosis that was unrelated to the vaccine,” but the article does not mention how it was determined that the multiple sclerosis was a preexisting condition.  Vaccine recipients have since had severe adverse reactions that resemble extreme multiple sclerosis.

The neurological disorders reported in this article are distinctly different from that reported later in the month.

Source:

See also, on this site:

Comments are closed.